Table 2.
Postoperative and 30-day outcomes among Progela and non-Progel cohorts
| Outcome, no. (%) unless noted otherwise | Non-Progel, n = 92 (%) | Progel, n = 84 (%) | p valueb |
|---|---|---|---|
| Intraoperative leak | 0 (0) | 2 (2.38) | 0.226 |
| Postoperative pneumothorax | 34 (36.96) | 34 (40.48) | 0.632 |
| 30-dy pneumothorax | 1 (1.12) | 0 (0) | > 0.99 |
| Postoperative leak | 16 (17.39) | 20 (23.81) | 0.326 |
| 30-d readmission | 8 (8.89) | 4 (4.76) | 0.283 |
| 30-d mortality | 1 (1.12) | 1 (1.19) | > 0.99 |
| Discharge with chest tube | 6 (6.67) | 8 (9.52) | 0.489 |
| Length of stay < 2 d | 71 (77.17) | 69 (82.14) | 0.414 |
| Chest tube duration, h | |||
| Median | 23.5 | 23 | 0.721 |
| Interquartile range | 20–29 | 20–27 | |
a
Progel Pleural Air Leak Sealant (CR Bard Inc, Warwick, RI).
b
Categorical p values calculated using χ2 or Fisher exact test; continuous p values calculated using Kruskal-Wallis test.